Analyst calls on Torrent Pharma, Zydus, and Hindalco were featured in the recommendations today.
Citi expects Torrent Pharma to sustain margin expansion driven by operating leverage in branded markets post a strong Q4 result.
Citi also views Hindalco positively due to stronger aluminum performance and debt reduction but recommends a 'sell' on Zydus.
Morgan Stanley and JPMorgan comment on India's strong fundamentals and foreign investor interest in the country.
Concerns on Zydus' margin contraction and positive outlook for Hindalco's aluminum performance were highlighted by analysts.
Foreign portfolio positioning in India is at its weakest since 2000, but views on India are showing signs of change.
Citi maintains a 'Buy' on Torrent Pharma with a target price of Rs 4,000, while JPMorgan hikes target price for Hindalco to Rs 720.
Goldman Sachs projects India to be among the top economies by 2050 and emphasizes the growth potential of emerging markets like India and Indonesia.
Stock recommendations and target prices for United Spirits, Bharat Electronics, and Dixon Technologies were also discussed.
Analysts provided insights on various sectors and companies like United Spirits, Bharat Electronics, and Dixon Technologies in the current market scenario.
India's market is expected to be more stock pickers' driven rather than macro-driven, with preferences for sectors like financials, consumer discretionary, and industrials.